Chad Therapeutics Reports Decline in 4th Quarter
Chad Therapeutics Inc. reported a net loss for the fourth quarter ended March 31 of $1.2 million compared with a net loss of $679,000 for the same period the previous year. Revenue decreased 9% to $2.8 million, compared with $3 million. For the year ended March 31, the company reported a net loss of $2.5 million, compared with a net loss of $1.5 million the previous year. Revenue dipped to $12.8 million from $14 million.
Chad Therapeutics makes oxygen conserving devices and systems for pulmonary patient care.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
